語系:
繁體中文
English
說明(常見問題)
回圖書館首頁
手機版館藏查詢
登入
回首頁
切換:
標籤
|
MARC模式
|
ISBD
Ultrasound mediated nanoparticle dru...
~
Mullin, Lee B.
FindBook
Google Book
Amazon
博客來
Ultrasound mediated nanoparticle drug delivery.
紀錄類型:
書目-電子資源 : Monograph/item
正題名/作者:
Ultrasound mediated nanoparticle drug delivery./
作者:
Mullin, Lee B.
面頁冊數:
156 p.
附註:
Source: Dissertation Abstracts International, Volume: 75-10(E), Section: B.
Contained By:
Dissertation Abstracts International75-10B(E).
標題:
Biomedical engineering. -
電子資源:
http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=3622426
ISBN:
9781303941641
Ultrasound mediated nanoparticle drug delivery.
Mullin, Lee B.
Ultrasound mediated nanoparticle drug delivery.
- 156 p.
Source: Dissertation Abstracts International, Volume: 75-10(E), Section: B.
Thesis (Ph.D.)--The University of North Carolina at Chapel Hill, 2014.
Ultrasound is not only a powerful diagnostic tool, but also a promising therapeutic technology that can be used to improve localized drug delivery. Microbubble contrast agents are micron sized encapsulated gas filled bubbles that are administered intravenously. Originally developed to enhance ultrasound images, microbubbles are highly echogenic due to the gas core that provides a detectable impedance difference from the surrounding medium. The core also allows for controlled response of the microbubbles to ultrasound pulses. Microbubbles can be pushed using acoustic radiation force and ruptured using high pressures. Destruction of microbubbles can increase permeability at the cellular and vascular level, which can be advantageous for drug delivery.
ISBN: 9781303941641Subjects--Topical Terms:
535387
Biomedical engineering.
Ultrasound mediated nanoparticle drug delivery.
LDR
:03347nmm a2200301 4500
001
2064105
005
20151109121422.5
008
170521s2014 ||||||||||||||||| ||eng d
020
$a
9781303941641
035
$a
(MiAaPQ)AAI3622426
035
$a
AAI3622426
040
$a
MiAaPQ
$c
MiAaPQ
100
1
$a
Mullin, Lee B.
$3
3178666
245
1 0
$a
Ultrasound mediated nanoparticle drug delivery.
300
$a
156 p.
500
$a
Source: Dissertation Abstracts International, Volume: 75-10(E), Section: B.
500
$a
Adviser: Paul A. Dayton.
502
$a
Thesis (Ph.D.)--The University of North Carolina at Chapel Hill, 2014.
520
$a
Ultrasound is not only a powerful diagnostic tool, but also a promising therapeutic technology that can be used to improve localized drug delivery. Microbubble contrast agents are micron sized encapsulated gas filled bubbles that are administered intravenously. Originally developed to enhance ultrasound images, microbubbles are highly echogenic due to the gas core that provides a detectable impedance difference from the surrounding medium. The core also allows for controlled response of the microbubbles to ultrasound pulses. Microbubbles can be pushed using acoustic radiation force and ruptured using high pressures. Destruction of microbubbles can increase permeability at the cellular and vascular level, which can be advantageous for drug delivery.
520
$a
Advances in drug delivery methods have been seen with the introduction of nanoparticles, nanometer sized objects often carrying a drug payload. In chemotherapy, nanoparticles can deliver drugs to tumors while limiting systemic exposure due to abnormalities in tumor vasculature such large gaps between endothelial cells that allow nanoparticles to enter into the interstitial space; this is referred to as the enhanced permeability and retention (EPR) effect. However, this effect may be overestimated in many tumors. Additionally, only a small percentage of the injected dose accumulates in the tumor, which most the nanoparticles accumulating in the liver and spleen.
520
$a
It is hypothesized that combining the acoustic activity of an ultrasound contrast agent with the high payload and extravasation ability of a nanoparticle, localized delivery to the tumor with reduced systemic toxicity can be achieved. This method can be accomplished by either loading nanoparticles onto the shell of the microbubble or through a coadministration method of both nanoparticles and microbubbles. The work presented in this dissertation utilizes novel and commercial nanoparticle formulations, combined with microbubbles and a variety of ultrasound systems. Ultrasound parameters are optimized to achieve maximum cell internalization of molecules and increased nanoparticle delivery to a cell layer on a coverslip. In-vivo studies demonstrate the possibility of using a lower dose of paclitaxel to slow tumor growth rates, increase doxorubicin concentration in tumor tissue, and enhance tumor delivery of fluorescent molecules through treatments that combine nanoparticles with ultrasound and microbubbles.
590
$a
School code: 0153.
650
4
$a
Biomedical engineering.
$3
535387
650
4
$a
Acoustics.
$3
879105
690
$a
0541
690
$a
0986
710
2
$a
The University of North Carolina at Chapel Hill.
$b
Biomedical Engineering.
$3
1678213
773
0
$t
Dissertation Abstracts International
$g
75-10B(E).
790
$a
0153
791
$a
Ph.D.
792
$a
2014
793
$a
English
856
4 0
$u
http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=3622426
筆 0 讀者評論
館藏地:
全部
電子資源
出版年:
卷號:
館藏
1 筆 • 頁數 1 •
1
條碼號
典藏地名稱
館藏流通類別
資料類型
索書號
使用類型
借閱狀態
預約狀態
備註欄
附件
W9296763
電子資源
11.線上閱覽_V
電子書
EB
一般使用(Normal)
在架
0
1 筆 • 頁數 1 •
1
多媒體
評論
新增評論
分享你的心得
Export
取書館
處理中
...
變更密碼
登入